Parkinson's disease: Clues to aetiology from a toxin
- 1 October 1984
- journal article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 311 (5986), 514
- https://doi.org/10.1038/311514a0
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitorsNature, 1984
- Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonismNature, 1984
- Neurochemical and behavioral effects of systematic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the ratEuropean Journal of Pharmacology, 1984
- AETIOLOGY OF PARKINSON'S DISEASEThe Lancet, 1983
- A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.Proceedings of the National Academy of Sciences of the United States of America, 1983
- Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog SynthesisScience, 1983
- Cigarette smoking and Parkinson diseaseNeurology, 1980
- Chronic parkinsonism secondary to intravenous injection of meperidine analoguesPsychiatry Research, 1979
- Stereotaxic Mapping of the Monoamine Pathways in the Rat Brain*Acta Physiologica Scandinavica, 1971
- Aromatic Amino Acids and Modification of ParkinsonismNew England Journal of Medicine, 1967